The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns
- PMID: 29642731
- DOI: 10.1080/14767058.2018.1460349
The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns
Abstract
Background: Acute kidney injury (AKI) in preterm neonates is becoming an increasingly recognized morbidity in the neonatal intensive care unit neonatal intensive care unit (NICU), yet its epidemiology, delineation and relation to numerous toxic exposures and common morbidities such as systemic hypertension is just evolving. With a frequency of the patent ductus arteriosus (PDA) as high as 70% in preterm infants born before 28-week gestation, the role of the hemodynamically significant PDA (hs-PDA) remains unclear. Objective: To determine if AKI and systemic hypertension is more common in extremely low gestational age newborns (ELGAN) with hs PDA compared to ELGAN with no or non-hs PDA using modified AKIN and Neonatal Risk, Injury, Failure, Loss of Kidney Function, and End-stage (N-RIFLE) scoring systems. Methods: This was a retrospective cohort study of infants ≤28 weeks gestational age born between 2010 and 2016 who had echocardiographic PDA evaluation completed for hemodynamical significance as well as serial serum creatinine and urine output measurement documented, needed for the two AKI scoring systems: modified AKIN (based on serial serum creatinine) and N-RIFLE (using urine output data). Blood pressure measurements and therapy were evaluated during the hospitalization and on the day of NICU discharge. Baseline characteristics and outcome variables were compared between the hs-PDA and no or non-hs PDA using unpaired t-tests for continuous variables and chi square tests for categorical data. Results: One hundred fifty-one infants were eligible of which 110 had hs-PDA. Infants with hs-PDA were smaller (777 versus 867 g, p = .026), less mature (25.8 versus 26.4 weeks, p = .023) and had greater exposure to nephrotoxic drugs (14 versus 9.4 days, p = .001). Other clinical and demographic variables were similar between the two groups. The overall incidence of AKI was not different between the hs-PDA and no PDA or non-hs PDA groups when evaluated by the acute kidney injury network (AKIN) or N-RIFLE staging; however, preterm newborns with hs-PDA demonstrated a trend towards increased risk of AKI injury (12.7 versus 0.02%, p = .06). The N-RIFLE and AKIN scoring systems demonstrated very poor degree of agreement (kappa = 0.00853) in our study. There was no difference in the rates of hypertension during the hospitalization as well as on the day of NICU discharge. Conclusion: Preterm neonates with hs-PDA had similar rates of AKI and hypertension as neonates with no or non-hs PDA.
Keywords: Acute kidney injury (AKI); acute renal injury; neonatal hypertension; patent ductus arteriosus; patent ductus arteriosus (PDA); preterm infants.
Similar articles
-
Urinary Neutrophil Gelatinase-associated Lipocalin in the evaluation of Patent Ductus Arteriosus and AKI in Very Preterm Neonates: a cohort study.BMC Pediatr. 2017 Jan 10;17(1):7. doi: 10.1186/s12887-016-0761-0. BMC Pediatr. 2017. PMID: 28068947 Free PMC article. Clinical Trial.
-
Patent ductus arteriosus is associated with acute kidney injury in the preterm infant.Pediatr Nephrol. 2019 Jun;34(6):1129-1139. doi: 10.1007/s00467-019-4194-5. Epub 2019 Jan 31. Pediatr Nephrol. 2019. PMID: 30706125
-
Neonatal acute kidney injury during indomethacin therapy: does it predict ductal closure?J Nephrol. 2023 Jul;36(6):1591-1597. doi: 10.1007/s40620-023-01634-8. Epub 2023 Apr 25. J Nephrol. 2023. PMID: 37097555
-
Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.Pediatr Neonatol. 2020 Apr;61(2):133-141. doi: 10.1016/j.pedneo.2019.10.002. Epub 2019 Oct 29. Pediatr Neonatol. 2020. PMID: 31740267 Review.
-
Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.Congenit Heart Dis. 2019 Jan;14(1):27-32. doi: 10.1111/chd.12691. Epub 2018 Oct 20. Congenit Heart Dis. 2019. PMID: 30343505 Review.
Cited by
-
Association Between Hypertensive Disorders of Pregnancy and Patent Ductus Arteriosus in Very Preterm Infants: A Bayesian Model-Averaged Meta-Analysis.Children (Basel). 2025 Jun 12;12(6):762. doi: 10.3390/children12060762. Children (Basel). 2025. PMID: 40564720 Free PMC article. Review.
-
Brain and renal oxygenation measured by NIRS related to patent ductus arteriosus in preterm infants: a prospective observational study.BMC Pediatr. 2021 Dec 9;21(1):559. doi: 10.1186/s12887-021-03036-w. BMC Pediatr. 2021. PMID: 34886825 Free PMC article.
-
Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.J Pers Med. 2022 Jul 14;12(7):1143. doi: 10.3390/jpm12071143. J Pers Med. 2022. PMID: 35887640 Free PMC article. Review.
-
Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data.Front Pediatr. 2020 Dec 21;8:613749. doi: 10.3389/fped.2020.613749. eCollection 2020. Front Pediatr. 2020. PMID: 33409262 Free PMC article.
-
Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis.Pediatr Nephrol. 2022 Feb;37(2):275-287. doi: 10.1007/s00467-021-05251-0. Epub 2021 Sep 16. Pediatr Nephrol. 2022. PMID: 34529137
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical